Publications by authors named "David Musselman"

Claim this Profile
A
Anomalous Origin of a Right Coronary Artery from the Pulmonary Artery in a Middle-Aged Woman.
Yogamaya Mantha, Mark Feldman, Andrew Assaf, Rakushumimarika Harada, David Musselman

JACC Case Rep· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial.
Jon T Giles, Naveed Sattar, Sherine Gabriel, Paul M Ridker, Steffen Gay, David Musselman

Arthritis Rheumatol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
Jessica C Wilson, Khaled Sarsour, Neil Collinson, Katie Tuckwell, David Musselman

Semin Arthritis Rheum· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
Jessica C Wilson, Khaled Sarsour, Neil Collinson, Katie Tuckwell, David Musselman

Semin Arthritis Rheum· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics.
Glynn Dennis, Cécile T J Holweg, Sarah K Kummerfeld, David F Choy, A Francesca Setiadi, David Musselman

Arthritis Res Ther· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy.
Vijay U Rao, Andrey Pavlov, Micki Klearman, David Musselman, Jon T Giles

Arthritis Rheumatol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.
Cem Gabay, Paul Emery, Ronald van Vollenhoven, Ara Dikranian, Rieke Alten, David Musselman

Lancet· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis